Immune Checkpoint Inhibitor-associated Periaortitis Detected on 18F-FDG PET/CT: A Rare Case of Nivolumab Toxicity
Résumé fourni par la source
We report a case of a 64-year-old male with metastatic non-small-cell lung carcinoma who was undergoing neoadjuvant chemoimmunotherapy with cisplatin, pemetrexed, and nivolumab.Restaging 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) demonstrated segmental, linear 18 F-FDG uptake along the abdominal aortic wall with corresponding crescentic soft-tissue thickening.Differential diagnoses included intramural hematoma, focal aortitis, atherosclerotic plaque, and tumor thrombus.CT angiography revealed a mildly enhancing periaortic soft-tissue rim involving a 5 cm infrarenal aortic segment, consistent with isolated periaortitis, likely induced by immunotherapy.Steroid therapy was initiated.Follow-up 18 F-FDG PET/CT showed complete metabolic resolution, supporting an immune-related etiology.18 F-FDG PET/CT played a crucial role in early recognition of this immune-related adverse event by sensitively detecting vascular inflammation and guiding further evaluation with CT angiography.Early PET-based detection enabled timely initiation of steroid therapy, preventing potential vascular complications.Keywords: 18 F-FDG PET/
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Immune Checkpoint Inhibitor-associated Periaortitis Detected on 18F-FDG PET/CT: A Rare Case of Nivolumab Toxicity
- Date Crossref
- 28/04/2026
- Éditeur
- Galenos Yayinevi
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.